T2 Biosystems, Inc. Operating Lease Cost
T2 Biosystems, Inc. reported Operating Lease Cost of $2.40 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-04-01
- T2 Biosystems, Inc. operating lease, cost for the quarter ending 2019-12-31 was $498.00K.
- T2 Biosystems, Inc. operating lease, cost for the quarter ending 2019-09-30 was $499.00K.
- T2 Biosystems, Inc. operating lease, cost for the quarter ending 2019-06-30 was $499.00K.
- T2 Biosystems, Inc. operating lease, cost for the quarter ending 2019-03-31 was $499.00K.
- T2 Biosystems, Inc. operating lease, cost for fiscal 2023 was $2.40M, a 0.17% decline from fiscal 2022.
- T2 Biosystems, Inc. operating lease, cost for fiscal 2022 was $2.40M, a 0.04% increase from fiscal 2021.
- T2 Biosystems, Inc. operating lease, cost for fiscal 2021 was $2.40M, a 23.44% increase from fiscal 2020.
- T2 Biosystems, Inc. operating lease, cost for fiscal 2020 was $1.95M, a 2.51% decline from fiscal 2019.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.40M 10-K · filed 2024-04-01 | |||
| 2022-12-31 | $2.40M 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $2.40M 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $1.95M 10-K · filed 2022-03-23 | |||
| 2019-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $997.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.50M derived: sum of 3 quarters · filed 2021-03-31 | $2.00M 10-K · filed 2021-03-31 |
| 2019-09-30 | $499.00K 10-Q · filed 2019-11-18 | $998.00K derived: sum of 2 quarters · filed 2019-11-18 | $1.50M 10-Q · filed 2019-11-18 | |
| 2019-06-30 | $499.00K 10-Q · filed 2019-08-02 | $998.00K 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $499.00K 10-Q · filed 2019-05-10 |